Ravinder Gandhi, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2025 Ford Ave, Wyandotte, MI 48192 Phone: 734-281-3080 Fax: 734-281-8815 |
Mark I Pensler, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2333 Biddle St, Wyandotte, MI 48192 Phone: 734-324-3528 Fax: 734-246-7110 |
News Archive
Next week, more than 1,200 people from 25 countries are expected to attend the 8th Annual World Stem Cell Summit in West Palm Beach, Fla., a gathering co-sponsored by Mayo Clinic. As those close to the science explore potential stem cell applications, many patients have questions about what stem cells are and how they are being used. Timothy Nelson, M.D., Ph.D., director of Mayo Clinic's Regenerative Medicine Consult Service, answers some of the most commonly asked questions about stem cells.
W. L. Gore & Associates (Gore) today announced the first human implants of the next generation Conformable GORE TAGĀ® Thoracic Endoprosthesis for the treatment of thoracic aortic aneurysms (TAAs). The first implants were performed by Joshua Rovin, MD and Eugene Murphy, MD, at Bayfront Medical Center and William McMillan, MD and Scott Schultz, MD, at North Memorial Medical Center.
New research published in the November 4, 2008 issue of Neurology, the medical journal of the American Academy of Neurology, found that ADHD affects the motor skills of boys more than girls. By examining age-related improvement of motor skills in children with and without ADHD, researchers from the Kennedy Krieger Institute in Baltimore, Md. found that girls with ADHD and their typically developing peers were more likely to be able to control their movements compared to boys with ADHD.
Eyes with central vision loss adapt by developing a new fixation point in a different part of the retina, called the preferred retinal location (PRL). Now for the first time, a new method makes it possible to identify PRLs in both eyes simultaneously, reports a study in the August issue of Optometry and Vision Science, official journal of the American Academy of Optometry.
Boehringer Ingelheim today announced results from a pre-specified, retrospective, un-blinded sub-analysis of the RE-LY trial the largest atrial fibrillation outcomes trial ever conducted were published in The Lancet.
› Verified 1 days ago